论文部分内容阅读
目的:考察市场上降糖中成药的质量。方法:用薄层色谱法与高效液相色谱法检测降糖中成药中的西药成分格列本脲。结果:少数生产厂家非法擅自在中成药中添加西药格列本脲。结论:大部分厂家是按处方生产降糖中成药,质量符合要求。
Objective: To investigate the quality of Chinese medicines for hypoglycemic drugs on the market. METHODS: The glibenclamide, a western drug ingredient in the hypoglycemic Chinese patent medicine, was detected by thin layer chromatography and high performance liquid chromatography. Results: A small number of manufacturers illegally added western medicine glibenclamide to proprietary Chinese medicines. Conclusion: Most manufacturers produce hypoglycemic Chinese medicines according to the prescription, and the quality meets the requirements.